Top Markets
#1 Islamic Coin Islamic Coin +152.56%
#2 Bitway Bitway +51.46%
#3 Wrapped STX (Velar) Wrapped STX (Velar) +37.70%
#4 Starpower Starpower +37.38%
#5 Pons Pons +33.82%
#6 aelf aelf +26.09%
#7 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +25.17%
#8 SkyAI SkyAI +19.36%
#9 Ocean Protocol Ocean Protocol +16.54%
#10 Decred Decred +14.08%
Coin of the day
Islamic Coin Islamic Coin
Settings
Language
ENGLISH
Currency
USD
Theme
Onco-Innovations Ltd. Onco-Innovations Ltd.

Onco-Innovations Ltd.

ONCO
Rank in Stocks #29551
Onco-Innovations Ltd. is a Canadian biotechnology company primarily focused on... Onco-Innovations Ltd. is a Canadian biotechnology company primarily focused on pioneering cancer research and developing oncology treatments. A significant offering in their portfolio is ONC010, a product specifically designed for use in cancer therapies. This enterprise was founded on September 16, 2021, and conducts its operations from its headquarters located in Calgary, Canada.
Share Price
$0.47705898
Last synced: 2026-07-15
Market Cap
$20.69M
Change (1 day)
3.17%
Change (1 year)
-65.19%
Country
CA
Trade Onco-Innovations Ltd. (ONCO)

Category

Healthcare
Revenue for Onco-Innovations Ltd. (ONCO)
Revenue in Aug 2026 TTM: 0
According to Onco-Innovations Ltd. latest financial reports the company's current revenue (TTM) is 0. In 2026 the company made a revenue of 0 equal to the revenue in the year 2026 that was 0. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for Onco-Innovations Ltd. from 2026 to 2026
Revenue at the end of each year
Year Revenue Change
Not enough data for the provided dates.
Revenue for similar companies or competitors
Company Revenue Revenue Difference Country
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $12.62B -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $6.02B -
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $15.70B -
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
 - -
KR